Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03302611
Other study ID # NMCSD.2017.0007
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 1, 2018
Est. completion date September 1, 2020

Study information

Verified date March 2023
Source United States Naval Medical Center, San Diego
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study uses a randomized controlled trial design to compare the psychological effects of surf therapy to hike therapy in active duty service members who have been diagnosed with major depressive disorder.


Description:

This prospective, longitudinal randomized controlled trial will enroll up to 86 active duty service members with major depressive disorder who are seeking surf or hike therapy as part of their standard medical care. Participants will be randomly assigned to receive 6 weeks of either surf or hike therapy. Assessor-administered and self-report measures will be completed at pre- and post-program, as well as three months following program completion. Participants also will complete brief, self-report assessments before and after each program activity session.


Recruitment information / eligibility

Status Completed
Enrollment 110
Est. completion date September 1, 2020
Est. primary completion date September 1, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Be a military service member seeking surf or hike therapy as part of the Wounded, Ill, and Injured Wellness program at Naval Medical Center San Diego; - Have medical clearance to participate in these programs; - Have a current diagnosis of Major Depressive Disorder based on DSM-5 criteria. Exclusion Criteria: - Service members who are currently receiving surf or hike therapy (i.e., have already started attending program sessions); - Service members who are currently pregnant

Study Design


Intervention

Behavioral:
Physical Activity-based Interventions
Participants will be randomized to one of two physical activity-based interventions, surf or hike therapy.

Locations

Country Name City State
United States Naval Medical Center San Diego San Diego California

Sponsors (2)

Lead Sponsor Collaborator
United States Naval Medical Center, San Diego Naval Health Research Center

Country where clinical trial is conducted

United States, 

References & Publications (2)

Walter KH, Otis NP, Glassman LH, Ray TN, Michalewicz-Kragh B, Kobayashi Elliott KT, Thomsen CJ. Comparison of surf and hike therapy for active duty service members with major depressive disorder: Study protocol for a randomized controlled trial of novel interventions in a naturalistic setting. Contemp Clin Trials Commun. 2019 Aug 21;16:100435. doi: 10.1016/j.conctc.2019.100435. eCollection 2019 Dec. — View Citation

Walter KH, Otis NP, Ray TN, Glassman LH, Beltran JL, Kobayashi Elliott KT, Michalewicz-Kragh B. A randomized controlled trial of surf and hike therapy for U.S. active duty service members with major depressive disorder. BMC Psychiatry. 2023 Feb 17;23(1):1 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Pain Rating Scale (PRS) The PRS is a self-report measure that assesses current level of pain. It consists of one item rated on an 11-point scale from 0 (no pain) to 10 (worst possible pain). 5 months
Primary Montgomery-Asberg Depression Rating Scale (MADRS) The MADRS is a widely used, semi-structured, clinical-interview assessment of depression symptom severity that is intended to be sensitive to change following an intervention. 5 months
Secondary PTSD Checklist (PCL-5) The PCL-5 is a self-report instrument assessing PTSD symptom severity. 5 months
Secondary Generalized Anxiety Disorder (GAD-7) The GAD-7 is a self-report instrument that assesses the presence and severity of generalized anxiety disorder. 5 months
Secondary Short Form Health Survey - 36 Item, Version 2 (SF-36) The SF-36 is a widely used questionnaire that assesses functioning physical and mental health based on eight summary measures. 5 months
Secondary Positive and Negative Affect scales (PANAS) PANAS is a self-report instrument that measures the extent of 20 feelings and emotions experienced within the past few hours. 5 months
Secondary Insomnia Severity Index (ISI) The ISI is a 7-item self-report measure that assesses the nature, severity, and impact of insomnia. 5 months
Secondary Patient Health Questionnaire (PHQ-9) The PHQ-9 is a self-report instrument that assesses the presence and severity 5 months
See also
  Status Clinical Trial Phase
Recruiting NCT05537558 - Precision Medicine for the Prediction of Treatment (PROMPT) Response (PROMPT)
Terminated NCT02192099 - Open Label Extension for GLYX13-C-202, NCT01684163 Phase 2
Completed NCT03142919 - Lipopolysaccharide (LPS) Challenge in Depression Phase 2
Recruiting NCT05547035 - Identification of Physiological Data by a Wearable Monitor in Subjects Suffering From Major Depression Disorders N/A
Terminated NCT02940769 - Neurobiological Effects of Light on MDD N/A
Recruiting NCT05892744 - Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression Phase 4
Recruiting NCT05537584 - SMART Trial to Predict Anhedonia Response to Antidepressant Treatment Phase 4
Active, not recruiting NCT05061706 - Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder Phase 3
Completed NCT04479852 - A Study of the Safety and Efficacy of SP-624 in the Treatment of Adults With Major Depressive Disorder Phase 2
Recruiting NCT04032301 - Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans Phase 1
Recruiting NCT05527951 - Enhanced Measurement-Based Care Effectiveness for Depression (EMBED) Study N/A
Completed NCT03511599 - Cycloserine rTMS Plasticity Augmentation in Depression Phase 1
Recruiting NCT04392947 - Treatment of Major Depressive Disorder With Bilateral Theta Burst Stimulation N/A
Recruiting NCT05895747 - 5-HTP and Creatine for Depression R33 Phase Phase 2
Recruiting NCT05273996 - Predictors of Cognitive Outcomes in Geriatric Depression Phase 4
Recruiting NCT05813093 - Interleaved TMS-fMRI in Ultra-treatment Resistant Depression N/A
Recruiting NCT05135897 - The Neurobiological Fundaments of Depression and Its Relief Through Neurostimulation Treatments
Enrolling by invitation NCT04509102 - Psychostimulant Augmentation of Repetitive TMS for the Treatment of Major Depressive Disorder Early Phase 1
Recruiting NCT06145594 - EMA-Guided Maintenance TMS for Depression N/A
Recruiting NCT06026917 - Assessing Dopamine Transporter Occupancy in the Patients With Depression Brain With Toludesvenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET) Phase 4

External Links